<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<REGINFO_RIN_DATA xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" RUN_DATE="2026-05-02-04:00" xsi:noNamespaceSchemaLocation="https://www.reginfo.gov/public/xml/REGINFO_XML_Ver10262011.xsd">
    <RIN_INFO>
        <RIN>3150-AI63</RIN>
        <PUBLICATION>
            <PUBLICATION_ID>201610</PUBLICATION_ID>
            <PUBLICATION_TITLE>The Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory Actions</PUBLICATION_TITLE>
        </PUBLICATION>
        <AGENCY>
            <CODE>3150</CODE>
            <NAME>Nuclear Regulatory Commission</NAME>
            <ACRONYM>NRC</ACRONYM>
        </AGENCY>
        <RULE_TITLE>Medical Use of Byproduct Material--Medical Event Definitions, Training and Experience, and Clarifying Amendments [NRC-2008-0175]</RULE_TITLE>
        <ABSTRACT><![CDATA[<!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>The final rule would amend the Commission's medical use regulations in part 35. The&nbsp;final rule addresses three ongoing rulemaking projects and several other related topics. First, this rule amends the reporting and notification requirements for a medical event for permanent implant brachytherapy. Second, the rule would amend: 1) The training and experience (T&amp;E)&nbsp;requirement for a written attestation statement for an individual who is certified by a recognized specialty board; requirements for authorized users, medical physicists, Radiation Safety Officers, and nuclear pharmacists; 2) the requirements for measuring molybdenum contamination and reporting of failed technetium and rubidium generators; and 3) allows Associate Radiation Safety Officers to be named on a medical license. Third, the rule makes changes to address a request filed in a petition for rulemaking (PRM-35-20) to exempt certain board-certified individuals from certain T&amp;E requirements (i.e., "grandfather" these individuals) so that they may be identified on a license or permit for materials and uses that they performed on or before October 24, 2005, the expiration date of the former subpart J of part 35 which contained the prior T&amp;E requirements.</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
</body>
</html>]]></ABSTRACT>
        <PRIORITY_CATEGORY>Substantive, Nonsignificant</PRIORITY_CATEGORY>
        <RIN_STATUS>Previously Published in The Unified Agenda</RIN_STATUS>
        <RULE_STAGE>Final Rule Stage</RULE_STAGE>
        <MAJOR>No</MAJOR>
        <UNFUNDED_MANDATE_LIST>
            <UNFUNDED_MANDATE>No</UNFUNDED_MANDATE>
        </UNFUNDED_MANDATE_LIST>
        <CFR_LIST>
            <CFR>10 CFR 35</CFR>
        </CFR_LIST>
        <LEGAL_AUTHORITY_LIST>
            <LEGAL_AUTHORITY>42 U.S.C. 2201</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 U.S.C. 5841</LEGAL_AUTHORITY>
        </LEGAL_AUTHORITY_LIST>
        <LEGAL_DLINE_LIST/>
        <RPLAN_ENTRY>No</RPLAN_ENTRY>
        <TIMETABLE_LIST>
            <TIMETABLE>
                <TTBL_ACTION>NPRM</TTBL_ACTION>
                <TTBL_DATE>07/21/2014</TTBL_DATE>
                <FR_CITATION>79 FR 42410</FR_CITATION>
            </TIMETABLE>
            <TIMETABLE>
                <TTBL_ACTION>NPRM Comment Period End</TTBL_ACTION>
                <TTBL_DATE>11/18/2014</TTBL_DATE>
            </TIMETABLE>
            <TIMETABLE>
                <TTBL_ACTION>Final Rule</TTBL_ACTION>
                <TTBL_DATE>12/00/2016</TTBL_DATE>
            </TIMETABLE>
        </TIMETABLE_LIST>
        <ADDITIONAL_INFO>The NRC received 69 comment letters containing over a hundred individual comments.  The commenters included several medical professional societies including the American Brachytherapy Society, American College of Radiology, Health Physics Society, American Society for Radiation Oncology, American Association of Physicists in Medicine, Council on Radionuclides and Radiopharmaceuticals, the Organization of the Agreement States, the Conference of Radiation Control Program Directors, individual States, practicing physicians, medical physicists, radiation safety officers, nuclear pharmacists, individual members of the public, and a member of the Congress.</ADDITIONAL_INFO>
        <RFA_REQUIRED>No</RFA_REQUIRED>
        <SMALL_ENTITY_LIST>
            <SMALL_ENTITY>No</SMALL_ENTITY>
        </SMALL_ENTITY_LIST>
        <GOVT_LEVEL_LIST>
            <GOVT_LEVEL>None</GOVT_LEVEL>
        </GOVT_LEVEL_LIST>
        <FURTHER_INFO_URL>www.regulations.gov (search for Docket ID NRC-2008-0175)</FURTHER_INFO_URL>
        <PUBLIC_COMMENT_URL>www.regulations.gov (search for Docket ID NRC-2008-0175) </PUBLIC_COMMENT_URL>
        <PRINT_PAPER>No</PRINT_PAPER>
        <INTERNATIONAL_INTEREST>No</INTERNATIONAL_INTEREST>
        <RELATED_RIN_LIST>
            <RELATED_RIN>
                <RIN>3150-AI26</RIN>
                <RIN_RELATION>Merged with</RIN_RELATION>
            </RELATED_RIN>
        </RELATED_RIN_LIST>
        <AGENCY_CONTACT_LIST>
            <CONTACT>
                <FIRST_NAME>Torre</FIRST_NAME>
                <LAST_NAME>Taylor</LAST_NAME>
                <AGENCY>
                    <CODE>3150</CODE>
                    <NAME>Nuclear Regulatory Commission</NAME>
                    <ACRONYM>NRC</ACRONYM>
                </AGENCY>
                <PHONE>301 415-7900</PHONE>
                <EMAIL>torre.taylor@nrc.gov</EMAIL>
                <MAILING_ADDRESS>
                    <STREET_ADDRESS>Office of Nuclear Material Safety and Safeguards,</STREET_ADDRESS>
                    <CITY>Washington</CITY>
                    <STATE>DC</STATE>
                    <ZIP>20555-0001</ZIP>
                </MAILING_ADDRESS>
            </CONTACT>
        </AGENCY_CONTACT_LIST>
    </RIN_INFO>
</REGINFO_RIN_DATA>
